Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Michael D. Parker"'
Autor:
Robert P. Franklin, Hailu Kinde, Michele T. Jay, Laura D. Kramer, Emily-Gene N. Green, Robert E. Chiles, Eileen Ostlund, Stan Husted, Jonathan Smith, Michael D. Parker
Publikováno v:
Emerging Infectious Diseases, Vol 8, Iss 3, Pp 283-288 (2002)
A yearling quarter horse, which was raised in southern California, received routine vaccinations for prevention of infection by Eastern equine encephalomyelitis virus (EEEV). One week later, severe neurologic signs developed, and the horse was humane
Externí odkaz:
https://doaj.org/article/c7ad9e7284e641b98cb6d6cab490113d
Autor:
Aimee Porter, Laurie J. Hartman, Pamela J. Glass, Michael D. Parker, Nancy A. Twenhafel, Luis DaSilva, Taylor B. Chance, Steven B Yee, Steven J. Kern, Rebecca Erwin-Cohen, David A. Norwood
Publikováno v:
Virology Journal
Background Licensed antiviral therapeutics and vaccines to protect against eastern equine encephalitis virus (EEEV) in humans currently do not exist. Animal models that faithfully recapitulate the clinical characteristics of human EEEV encephalitic d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d48263b8a87c926d54addb895c8a6a
http://europepmc.org/articles/PMC5297202
http://europepmc.org/articles/PMC5297202
Autor:
Michael D. Parker, Marilyn J. Buckley, Mary Kate Hart, Pamela J. Glass, Vanessa R. Melanson, David Norwood
Publikováno v:
Journal of Virology. 84:12683-12690
Six monoclonal antibodies were isolated that exhibited specificity for a furin cleavage site deletion mutant (V3526) of Venezuelan equine encephalitis virus (VEEV). These antibodies comprise a single competition group and bound the E3 glycoprotein of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce56bd53281f98d8ab35cc8af01988c8
https://doi.org/10.1128/jvi.01345-10
https://doi.org/10.1128/jvi.01345-10
Autor:
Mary Kate Hart, Michael D. Parker, Cathleen M. Lind, Patricia Garcia, Russell R. Bakken, Pamela J. Glass, Erin Jenkins, Donald L. Fine, Shannon S. Martin
Publikováno v:
Vaccine. 28:3143-3151
V3526, a genetically modified strain of Venezuelan equine encephalitis virus (VEEV), was formalin inactivated for evaluation as a next generation vaccine candidate for VEEV. In this study, we tested formalin-inactivated V3526 (fV3526) with and withou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc251b154f65a450b7ad218e527a6367
https://doi.org/10.1016/j.vaccine.2010.02.056
https://doi.org/10.1016/j.vaccine.2010.02.056
Autor:
Christopher P. Locher, Cathleen M. Lind, Russell R. Bakken, Michael D. Parker, Connie S. Schmaljohn, Michelle J. Richards, Lesley C. Dupuy, Madan M. Paidhungat, Robert G. Whalen
Publikováno v:
Vaccine. 27:4152-4160
We employed directed molecular evolution to improve the cross-reactivity and immunogenicity of the Venezuelan equine encephalitis virus (VEEV) envelope glycoproteins. The DNA encoding the E1 and E2 proteins from VEEV subtypes IA/B and IE, Mucambo vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fad33c8fe92ad11578eae6f56521935
https://doi.org/10.1016/j.vaccine.2009.04.049
https://doi.org/10.1016/j.vaccine.2009.04.049
Autor:
Michael D. Parker, Michael J. Turell
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 78:328-332
In an attempt to improve the current live, attenuated vaccine (TC-83) for Venezuelan equine encephalitis virus (VEEV), specific mutations associated with attenuation of VEEV in rodent models were inserted into a full-length cDNA clone of the Trinidad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c9e673f7e8108a8aeda542b14607d03
https://doi.org/10.4269/ajtmh.2008.78.328
https://doi.org/10.4269/ajtmh.2008.78.328
Publikováno v:
Advanced Drug Delivery Reviews. 57:1293-1314
The heightened concerns about bioterrorism and the use of biowarfare agents have prompted substantial increased efforts towards the development of vaccines against a wide range of organisms, toxins, and viruses. An increasing variety of platforms and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::881b1ffa478a6b1227918d3511510527
https://doi.org/10.1016/j.addr.2005.01.011
https://doi.org/10.1016/j.addr.2005.01.011
Autor:
Matthew G. Lackemeyer, Cathleen M. Lind, Douglas S. Reed, Lawrence J. Sullivan, Michael D. Parker, William D. Pratt
Publikováno v:
Vaccine. 23:3139-3147
Two live, attenuated strains of Venezuelan equine encephalitis virus (VEE), IE1150K and V3526, were administered to macaques to determine if they could elicit protection against an aerosol challenge with virulent VEE virus of the IE variety (VEEV-IE)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3edc00f7401a244d4b38895292a8214
https://doi.org/10.1016/j.vaccine.2004.12.023
https://doi.org/10.1016/j.vaccine.2004.12.023
Publikováno v:
The Journal of Infectious Diseases. 189:1013-1017
Because Venezuelan equine encephalitis viruses (VEEVs) are infectious by aerosol, they are considered to be a biological-weapons threat. Nonhuman-primate models are needed to evaluate the efficacy of candidate vaccines. In the present study, cynomolg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdcf8c5768fbb28952572137d25718b2
https://doi.org/10.1086/382281
https://doi.org/10.1086/382281
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 68:218-221
Specific mutations associated with attenuation of Venezuelan equine encephalitis (VEE) virus in rodent models were identified during efforts to develop an improved VEE vaccine. Analogous mutations were produced in full-length cDNA clones of the Cba 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d55b68596f052ae91c710f3ab09d0feb
https://doi.org/10.4269/ajtmh.2003.68.218
https://doi.org/10.4269/ajtmh.2003.68.218